Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 3
2010 1
2011 2
2015 2
2016 1
2017 2
2018 5
2019 2
2020 5
2021 2
2022 1
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Proteasome inhibitor therapy for antibody-mediated rejection.
Woodle ES, Walsh RC, Alloway RR, Girnita A, Brailey P. Woodle ES, et al. Among authors: brailey p. Pediatr Transplant. 2011 Sep;15(6):548-56. doi: 10.1111/j.1399-3046.2011.01543.x. Pediatr Transplant. 2011. PMID: 21884344 Review.
Corticosteroid elimination: the Cincinnati experience.
Woodle ES, Alloway R, Rike A, Roy-Chaudhury P, Tevar A, Susskind B, Everly J, Mogilishetty G, Brailey P, Govil A, Rudich S, First MR, Alexander JW, Munda R, Cardi M, Arend L. Woodle ES, et al. Among authors: brailey p. Clin Transpl. 2007:51-60. Clin Transpl. 2007. PMID: 18637458 Review.
Restriction Factor Expression in Vertically Infected Children Living With HIV-1.
Bortlik M, Copertino DC Jr, Brailey PM, Beckerle GA, Ormsby CE, Rosenberg MG, Wiznia AA, Raposo RAS, Nixon DF, de Mulder Rougvie M. Bortlik M, et al. Among authors: brailey pm. Pediatr Infect Dis J. 2021 Feb 1;40(2):144-146. doi: 10.1097/INF.0000000000002924. Pediatr Infect Dis J. 2021. PMID: 33395209
A prospective, iterative, adaptive trial of carfilzomib-based desensitization.
Tremblay S, Driscoll JJ, Rike-Shields A, Hildeman DA, Alloway RR, Girnita AL, Brailey PA, Woodle ES. Tremblay S, et al. Among authors: brailey pa. Am J Transplant. 2020 Feb;20(2):411-421. doi: 10.1111/ajt.15613. Epub 2019 Oct 23. Am J Transplant. 2020. PMID: 31550069 Free PMC article. Clinical Trial.
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors.
Archer S, Brailey PM, Song M, Bartlett PD, Figueiredo I, Gurel B, Guo C, Brucklacher-Waldert V, Thompson HL, Akinwale J, Boyle SE, Rossant C, Birkett NR, Pizzey J, Maginn M, Legg J, Williams R, Johnston CM, Bland-Ward P, de Bono JS, Pierce AJ. Archer S, et al. Among authors: brailey pm. Clin Cancer Res. 2024 Apr 15;30(8):1595-1606. doi: 10.1158/1078-0432.CCR-23-3052. Clin Cancer Res. 2024. PMID: 38593226 Free PMC article.
IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.
Raposo RAS, de Mulder Rougvie M, Paquin-Proulx D, Brailey PM, Cabido VD, Zdinak PM, Thomas AS, Huang SH, Beckerle GA, Jones RB, Nixon DF. Raposo RAS, et al. Among authors: brailey pm. JCI Insight. 2017 Jan 12;2(1):e85811. doi: 10.1172/jci.insight.85811. JCI Insight. 2017. PMID: 28097226 Free PMC article.
Prospective iterative trial of proteasome inhibitor-based desensitization.
Woodle ES, Shields AR, Ejaz NS, Sadaka B, Girnita A, Walsh RC, Alloway RR, Brailey P, Cardi MA, Abu Jawdeh BG, Roy-Chaudhury P, Govil A, Mogilishetty G. Woodle ES, et al. Among authors: brailey p. Am J Transplant. 2015 Jan;15(1):101-18. doi: 10.1111/ajt.13050. Am J Transplant. 2015. PMID: 25534446 Free article.
27 results